Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Millennium Review
  • Published:

Design and application of HSV vectors for neuroprotection

Gene Therapy volume 7, pages 115–119 (2000)Cite this article

Abstract

Herpes simplex virus has been extensively genetically modified for gene transfer to nerve and other tissues, to create vectors that are devoid of viral gene expression and toxicity. Recombinant vectors have been engineered to express genes which protect neurons against toxic insults resulting in cell death, including nerve growth factor (NGF) and anti-apoptotic genes (eg bcl-2). This review describes experiments using HSV vectors expressing these gene products and their potential protective role in ameliorating neurodegenerative processes in animal model systems.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Fink D et al. Gene transfer to neurons using herpes simplex virus-based vectors Ann Rev Neurosci 1996 19: 265–287

    Article  CAS  PubMed  Google Scholar 

  2. Roizman B, Sears A . Herpes simplex viruses and their replication. In: Fields BN et al (eds) Fields Virology, vol. 2 Raven Press: Philadelphia 1996 pp 2231–2295

    Google Scholar 

  3. Herold B et al. Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulfate and glycoprotein B J Gen Virol 1994 75: 1211–1222

    Article  CAS  PubMed  Google Scholar 

  4. Tal-Singer R et al. Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules J Virol 1995 69: 4471–4483

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Montgomery RI et al. Herpes simplex virus 1 entry into cells mediated by a novel member of the TNF/NGF receptor family Cell 1996 87: 427–436

    Article  CAS  PubMed  Google Scholar 

  6. Geraghty RJ et al. Entry of alpha herpes viruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor Science 1998 280: 1618–1620

    Article  CAS  PubMed  Google Scholar 

  7. Dixon RAF, Schaffer PA . Fine-structure mapping and functional analysis of temperature-sensitive mutants in the gene encoding the herpes simplex virus type 1 immediate early protein VP175 J Virol 1980 36: 189–203

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Preston C . Control of herpes simplex virus type 1 mRNA synthesis in cells infected with wild-type virus or the temperature-sensitive mutant tsK J Virol 1979 29: 275–284

    CAS  PubMed  PubMed Central  Google Scholar 

  9. DeLuca NA, McCarthy AM, Schaffer PA . Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate–early regulatory protein ICP4 J Virol 1985 56: 558–570

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Samaniego LA, Neiderhiser L, DeLuca NA . Persistence and expression of the herpes simplex virus genome in the absence of immediate–early proteins J Virol 1998 72: 3307–3320

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Wu N et al. Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate–early genes encoding ICP4, ICP27, and ICP22 J Virol 1996 70: 6358–6368

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Hobbs W, DeLuca N . Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0 J Virol 1999 73: 8245–8255

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Wrzoa H, Rapp F . Establishment of latency in vitro with herpes simplex virus temperature-sensitive mutants at nonpermissive temperature Virus Res 1987 8: 301–308

    Article  Google Scholar 

  14. Spivack JG, Fraser NW . Detection of herpes simplex virus type 1 transcripts during latent infection in mice J Virol 1987 61: 3841–3847

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Spivack J, Fraser N . Expression of herpes simplex virus type 1 latency-associated transcripts in trigeminal ganglia of mice during acute infection and reactivation of latent infection J Virol 1988 62: 1479–1485

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Ramakrishnan R et al. Competitive quantitative polymerase chain reaction (PCR) analysis of herpes simplex virus type 1 DNA and LAT RNA in latently infected cells of the rat brain J Virol 1994 68: 1864–1870

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Ramakrishnan R et al. Detection of herpes simplex virus type 1 latency-associated transcript expression in trigeminal ganglia by in situ reverse transcriptase PCR J Virol 1996 70: 6519–6523

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Goins WF et al. Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglia neurons from peroxide toxicity J Virol 1999 73: 519–532

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Wolfe DP et al. Long term systemic delivery of nerve growth factor for treatment of peripheral neuropathies using replication defective genomic HSV vectors Soc Neurosci Abstr 1999 25: 2279

    Google Scholar 

  20. Yamada M et al. HSV vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine induced degeneration of neurons in the substantia nigra in vivo Proc Natl Acad Sci USA 1999 96: 4078–4083

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the NIH (5R01EY11528-03), (2R01CA66141-10A2), (5R01AR4452603) Department of Veterans Affairs and US Army (USAMRC 98292035), (DAMD179818626).

Author information

Authors and Affiliations

  1. Departments of Neurology and Molecular Genetics and Biochemistry, University of Pittsburgh, School of Medicine and GRECC, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA

    D J Fink

  2. Department of Molecular Genetics and Biochemistry, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA

    N A DeLuca, D P Wolfe & J C Glorioso

  3. Departments of Neurology and Molecular Genetics and Biochemistry, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA

    M Yamada

Authors
  1. D J Fink
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N A DeLuca
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D P Wolfe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J C Glorioso
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fink, D., DeLuca, N., Yamada, M. et al. Design and application of HSV vectors for neuroprotection. Gene Ther 7, 115–119 (2000). https://doi.org/10.1038/sj.gt.3301118

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301118

Keywords

This article is cited by

Search

Advanced search

Quick links